Validation and Inverse Analysis of The Athletic Shoulder Test (ASH). (NCT06763107) | Clinical Trial Compass
CompletedNot Applicable
Validation and Inverse Analysis of The Athletic Shoulder Test (ASH).
Spain21 participantsStarted 2025-01-10
Plain-language summary
To validate both the Athletic Shoulder (ASH) test, conducted on rugby players, and its inverse, the Inverse Athletic Shoulder (IASH) test, for swimmers. This involves assessing the strength relationship between shoulder flexion and extension at three different adduction angles (180º, 135º, 90º) to identify potential injuries associated with these imbalances.
Who can participate
Age range
14 Years – 18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* High-performance swimmers.
* Aged between 14 and 18 years.
* No acute injuries in the cervical or scapular region.
* Ability to perform the ASH and IASH tests without compensatory movements.
Exclusion Criteria:
* Acute injuries in the cervical or scapular region.
* Inability to maintain proper positioning during the tests due to lack of adequate mobility or strength.
* Refusal to sign informed consent (or legal guardian's consent for minors).
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Intraclass Correlation Coefficient (ICC) for ASH Test
Timeframe: Measured at two time points: baseline (Day 0) and follow-up (Day 2).
2
Intraclass Correlation Coefficient (ICC) for IASH Test
Timeframe: Measured at two time points: baseline (Day 0) and follow-up (Day 2).
3
Coefficient of Variation (CV) for ASH and IASH Tests
Timeframe: Measured at two time points: baseline (Day 0) and follow-up (Day 2).
4
Minimum Detectable Change (MDC) for ASH and IASH Tests
Timeframe: Measured at two time points: baseline (Day 0) and follow-up (Day 2).
5
Force Ratios Between ASH and IASH Tests
Timeframe: Measured at two time points: baseline (Day 0) and follow-up (Day 2).
6
Comparison of Shoulder Strength Between Preferred and Non-Preferred Breathing Sides
Timeframe: Measured at two time points: baseline (Day 0) and follow-up (Day 2).